PharmaEssentia Corporation (TPE:6446)
Taiwan · Delayed Price · Currency is TWD 1,195.00
+35.00 (3.02%)
Jun 25, 2026, 1:30 PM CST
PharmaEssentia Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, PharmaEssentia stock has a consensus rating of "Buy" and an average price target of $810.50. The average 1-year stock price forecast is 32.18% lower than the current stock price, while the lowest is $550.00 (-53.97%) and the highest is $1,138 (-4.77%).
Price Target: $810.50 (-32.18%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PharmaEssentia stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 6 | 6 |
Financial Forecast
Revenue This Year
23.96B
from 15.63B
Increased by 53.26%
Revenue Next Year
37.07B
from 23.96B
Increased by 54.69%
EPS This Year
22.95
from 13.59
Increased by 68.89%
EPS Next Year
33.99
from 22.95
Increased by 48.09%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is TWD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.3B | ||
| Avg | 24.0B | ||
| Low | 21.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 81.1% | ||
| Avg | 53.3% | ||
| Low | 37.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 30.97 | ||
| Avg | 22.95 | ||
| Low | 15.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 127.9% | ||
| Avg | 68.9% | ||
| Low | 12.2% |